Biotech Values

[backstroke_]

What makes you guys think any of manufacturing steps would be altered by licensing with 4DMT?

My understanding is 4DMT is focused on front-end working through millions of slightly different versions of the AAV vectors, evolving them over multiple generations, looking for characteristics that meet the licensee target(retina, cardiac, liver, etc..) requirements.

Once suitable variants are found, then licensee would take those new vectors and use them within their existing development/manufacturing workflow.